These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 5671692

  • 21. [Endogenous and exogenous fibrinolysis].
    Perlick E, Wilfert K.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):28-32. PubMed ID: 4189368
    [No Abstract] [Full Text] [Related]

  • 22. [Activation of intravascular coagulation and fibrinolysis in cases of APL].
    Asakura H, Saito M, Jokaji H, Uotani C, Kumabashiri I, Matsuda T.
    Rinsho Byori; 1989 Apr; Spec No 81():224-8. PubMed ID: 2526885
    [No Abstract] [Full Text] [Related]

  • 23. Longitudinal stability of coagulation, fibrinolysis, and inflammation factors in stored plasma samples.
    Lewis MR, Callas PW, Jenny NS, Tracy RP.
    Thromb Haemost; 2001 Dec; 86(6):1495-500. PubMed ID: 11776319
    [Abstract] [Full Text] [Related]

  • 24. Studies on thrombolysis with streptokinase. IV. Immunofluorescent investigations on the fibrin pattern and the content of plasminogen and of plasma-plasmin-inhibitors in clots and thrombi of various age.
    Gottlob R, el-Nashef B, Donas P, Piza F, Kolb R.
    Thromb Diath Haemorrh; 1973 May 10; 29(2):393-407. PubMed ID: 4586907
    [No Abstract] [Full Text] [Related]

  • 25. Changes in blood coagulation and fibrinolysis in the nephrotic syndrome.
    Thomson C, Forbes CD, Prentice CR, Kennedy AC.
    Q J Med; 1974 Jul 10; 43(171):399-407. PubMed ID: 4547474
    [No Abstract] [Full Text] [Related]

  • 26. 4-aminomethylbicyclo[2.2.2]-octane-1-carboxylic acid a new potent antifibrinolytic agent. Its evaluation by in vitro assay procedures.
    Baumgarten W, Priester LI, Stiller DW, Duncan AE, Ciminera JL, Loeffler LJ.
    Thromb Diath Haemorrh; 1969 Nov 15; 22(2):263-72. PubMed ID: 5380948
    [No Abstract] [Full Text] [Related]

  • 27. [Biologic data furnished by the experience of thrombolytic treatments with streptokinase].
    Samama M, Yver J, Casubolo L, Soria J, Bousser J.
    Nouv Rev Fr Hematol; 1968 Nov 15; 8(1):84-92. PubMed ID: 4232155
    [No Abstract] [Full Text] [Related]

  • 28. Endothelium and fibrinolysis.
    Todd AS.
    Bibl Anat; 1973 Nov 15; 12():98-105. PubMed ID: 4275208
    [No Abstract] [Full Text] [Related]

  • 29. Coagulation factors and components of the fibrinolytic system in lymph and blood in dogs.
    Leandoer L, Bergentz SE, Nilsson IM.
    Thromb Diath Haemorrh; 1968 Mar 31; 19(1):129-35. PubMed ID: 5652223
    [No Abstract] [Full Text] [Related]

  • 30. [Study on the fibrinolysis in renal hypertension].
    Guseĭnov ChS, Khundadze SSh, Belichenko IA, Smirnova LI, Kurate LV.
    Klin Med (Mosk); 1969 Jul 31; 47(7):70-5. PubMed ID: 5385093
    [No Abstract] [Full Text] [Related]

  • 31. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
    Veremeenko KN, Kizim AI.
    Vopr Med Khim; 1984 Jul 31; 30(5):13-22. PubMed ID: 6084892
    [Abstract] [Full Text] [Related]

  • 32. [Is lipoprotein (a) a link between atherosclerosis and thrombosis?].
    Ehnholm C, Jauhiainen M.
    Duodecim; 1990 Jul 31; 106(8):604-7. PubMed ID: 1670247
    [No Abstract] [Full Text] [Related]

  • 33. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H, Mori Y, Okabayashi K, Gabazza EC, Kushiya F, Watanabe M, Nishikawa M, Shiku H, Nobori T.
    Am J Hematol; 2003 Jan 31; 72(1):1-7. PubMed ID: 12508260
    [Abstract] [Full Text] [Related]

  • 34. [Coagulation and fibrinolysis proteins in nephrotic syndromes in children].
    Loirat C, Pillion G, Schlegel N, Douenias R, Mathieu H.
    Arch Fr Pediatr; 1979 Nov 31; 36(9 Suppl):LVI-LXIII. PubMed ID: 539878
    [Abstract] [Full Text] [Related]

  • 35. Antifibrinolytics gynaecology and obstetrics.
    Koutský J, Hladovec J.
    Acta Univ Carol Med (Praha); 1975 Nov 31; 21(5-6):235-386. PubMed ID: 132853
    [No Abstract] [Full Text] [Related]

  • 36. [Blood coagulation mechanism from the viewpoint of molecular biochemistry: Mechanism of fibrinolysis].
    Matsuda T.
    Rinsho Byori; 1985 Sep 31; 33(9):982-8. PubMed ID: 2416968
    [No Abstract] [Full Text] [Related]

  • 37. On coagulation and fibrinolysis in renal failure.
    Larsson SO.
    Scand J Haematol Suppl; 1971 Sep 31; 15():1-59. PubMed ID: 5284430
    [No Abstract] [Full Text] [Related]

  • 38. [Comparative data on the coaguability of blood in hypertensive disease and arteriosclerosis].
    Libenson RT.
    Kardiologiia; 1970 Oct 31; 10(10):135-6. PubMed ID: 5504108
    [No Abstract] [Full Text] [Related]

  • 39. [Role of changes in the state of the blood coagulation and fibrinolysis system in the pathogenesis of myocardial infarct and atherosclerosis].
    Andreenko GV.
    Kardiologiia; 1974 Nov 31; 14(11):139-46. PubMed ID: 4610256
    [No Abstract] [Full Text] [Related]

  • 40. [Changes in the fibrinolytic system of the blood in patients with hypertension with coronary arteriosclerosis and circulatory insufficiency].
    Aslanian NL, Dolabchian ZL, Shukhian VM, Demirchian AKh, Khachaturova IA.
    Kardiologiia; 1972 Jul 31; 12(7):106-9. PubMed ID: 4670631
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.